title: Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia.
abstract: BACKGROUND
  Glanzmann Thrombasthenia (GT) is a genetic platelet dysfunction and a life threatening disease. Ankaferd Blood Stopper (ABS) is a topical hemostatic agent of herbal origin which has been recently made available for clinical use. Its hemostatic effect is independent from blood clotting factors and occurs as a result of the aggregation of focal red blood cells by an encapsulated protein web.
  
  
  METHODS
  In this paper, a patient with GT is presented in whom 3 months of gastrointestinal bleeding refractory to all medical therapies was controlled within a short time of using oral ABS.
  
  
  CONCLUSIONS
  The difference between this patient and other cases presented in the medical literature is the oral use of ABS. Thus, this patient may contribute to the medical community in showing the safety and efficacy of systemic (oral) ABS in patients with disorders of coagulation. However, there is a need for more patient experiences.
authors.affiliation: Department of Hematology, Pamukkale University Faculty of Medicine, Denizli, Turkey.
authors.forename: Sibel Kabukçu
authors.initials: SK
authors.lastname: Hacıoğlu
authors.affiliation: Department of Hematology, Pamukkale University Faculty of Medicine, Denizli, Turkey.
authors.forename: Mehmet Hilmi
authors.initials: MH
authors.lastname: Doğu
authors.affiliation: Department of Hematology, Pamukkale University Faculty of Medicine, Denizli, Turkey.
authors.forename: İsmail
authors.initials: İ
authors.lastname: Sarı
authors.affiliation: Department of Hematology, Pamukkale University Faculty of Medicine, Denizli, Turkey.
authors.forename: Ali
authors.initials: A
authors.lastname: Keskin
keywords: Ankaferd Blood Stopper; Glanzmann thrombasthenia; disorders of hemostasis; oral systemic administration